Reduced Expression of Erythropoietin After Intravitreal Ranibizumab in Proliferative Diabetic Retinopathy Patients—Retrospective Interventional Study

Purpose: To evaluate the expressions of erythropoietin (EPO) and vascular endothelial growth factor (VEGF) in the vitreous and fibrovascular membranes (FVMs) of proliferative diabetic retinopathy (PDR) after the intravitreal injection of ranibizumab (IVR) and further explore the relationship between...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li, Feng, Jing, Shi, Yanhong, Luan, Fuxiao, Ma, Fang, Wang, Yingjie, Yang, Weiqiang, Tao, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490617/
https://www.ncbi.nlm.nih.gov/pubmed/34621759
http://dx.doi.org/10.3389/fmed.2021.710079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490617/
https://www.ncbi.nlm.nih.gov/pubmed/34621759
http://dx.doi.org/10.3389/fmed.2021.710079

Ejemplares similares